These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22844439)

  • 1. The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning.
    Guo Y; Tukaye DN; Wu WJ; Zhu X; Book M; Tan W; Jones SP; Rokosh G; Narumiya S; Li Q; Bolli R
    PLoS One; 2012; 7(7):e41178. PubMed ID: 22844439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats.
    Sato H; Bolli R; Rokosh GD; Bi Q; Dai S; Shirk G; Tang XL
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2557-64. PubMed ID: 17704286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
    Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
    Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice.
    Guo Y; Bao W; Wu WJ; Shinmura K; Tang XL; Bolli R
    Basic Res Cardiol; 2000 Dec; 95(6):479-84. PubMed ID: 11192369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene.
    Guo Y; Jones WK; Xuan YT; Tang XL; Bao W; Wu WJ; Han H; Laubach VE; Ping P; Yang Z; Qiu Y; Bolli R
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11507-12. PubMed ID: 10500207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
    Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
    Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
    Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits.
    Takano H; Tang XL; Bolli R
    Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2350-9. PubMed ID: 11045972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.
    Bolli R; Shinmura K; Tang XL; Kodani E; Xuan YT; Guo Y; Dawn B
    Cardiovasc Res; 2002 Aug; 55(3):506-19. PubMed ID: 12160947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS.
    Guo Y; Stein AB; Wu WJ; Zhu X; Tan W; Li Q; Bolli R
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2251-7. PubMed ID: 16006548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning.
    Shinmura K; Xuan YT; Tang XL; Kodani E; Han H; Zhu Y; Bolli R
    Circ Res; 2002 Mar; 90(5):602-8. PubMed ID: 11909825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [COX-2 or nNOS mediates cardioprotection during the final stage of the late phase of ischemic preconditioning].
    Xu Q; Tang B; Zhang N; Song L; Zhang Z; Chen Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec; 25(6):1411-4. PubMed ID: 19166220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene.
    Smith RM; Suleman N; McCarthy J; Sack MN
    Cardiovasc Res; 2002 Aug; 55(3):553-60. PubMed ID: 12160952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice.
    Guo Y; Flaherty MP; Wu WJ; Tan W; Zhu X; Li Q; Bolli R
    Basic Res Cardiol; 2012 Sep; 107(5):288. PubMed ID: 22864681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of cyclooxygenase-2 upregulation in late preconditioning.
    Xuan YT; Guo Y; Zhu Y; Han H; Langenbach R; Dawn B; Bolli R
    J Mol Cell Cardiol; 2003 May; 35(5):525-37. PubMed ID: 12738234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits.
    Tang XL; Xuan YT; Zhu Y; Shirk G; Bolli R
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1273-80. PubMed ID: 14684373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.
    Bley KR; Bhattacharya A; Daniels DV; Gever J; Jahangir A; O'Yang C; Smith S; Srinivasan D; Ford AP; Jett MF
    Br J Pharmacol; 2006 Feb; 147(3):335-45. PubMed ID: 16331286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
    Kodani E; Xuan YT; Shinmura K; Takano H; Tang XL; Bolli R
    Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1943-57. PubMed ID: 12384473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction.
    Stein AB; Guo Y; Tan W; Wu WJ; Zhu X; Li Q; Luo C; Dawn B; Johnson TR; Motterlini R; Bolli R
    J Mol Cell Cardiol; 2005 Jan; 38(1):127-34. PubMed ID: 15623429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo.
    Alcindor D; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
    Anesthesiology; 2004 Mar; 100(3):547-54. PubMed ID: 15108967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.